IP Library Granted Patent US 9,211,387
Granted Patent B2
US 9,211,387 · App. 12/819,549 · Granted Dec 15, 2015

Infant nasal interface mask

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,211,387
App. No.
12/819,549
Granted
Dec 15, 2015
Kind
B2
Abstract

An infant nasal interface mask for use with a nasal continuous positive airway pressure (nCPAP) system including a mask body and a base. The mask body forms a cavity and is defined by a leading portion, an intermediate shell portion, and a trailing portion. The leading portion terminates in a leading edge forming an aperture open to the cavity and having a generally triangular shape for placement over a patient's nose. The trailing portion includes a bellows segment characterized by an increased flexibility as compared to a flexibility of the intermediate shell portion. The base extends from the trailing portion opposite the leading portion and forms at least one longitudinal passage extending through a thickness of the base and fluidly connected to the cavity. The intermediate shell portion is laterally pivotable relative to the base via the bellows segment.

Claims (39)

1. An nasal interface mask for use with a nasal continuous positive airway pressure (nCPAP) system, the nasal interface mask comprising:

a mask body forming a cavity and defined by a leading portion, an intermediate shell portion, and a trailing portion, wherein:

the leading portion terminates in a leading edge forming an aperture open to the cavity and having a generally triangular shape for placement over a patient's nose, and

the trailing portion includes a bellows segment disposed within the cavity and characterized by an increased flexibility as compared to a flexibility of the intermediate shell portion; and

a base extending from the trailing portion opposite the leading portion, the base forming at least one passage extending longitudinally through a thickness of the base from an opening in a rear face of the base and permanently fluidly open to the aperture, wherein an axis of the opening intersects the aperture;

wherein the intermediate shell portion is longitudinally moveable and laterally pivotable relative to the base via the bellows segment,

wherein the mask body includes a side wall forming at least the intermediate shell and trailing portions, and

wherein the bellows segment is characterized by the side wall having a reduced cross-sectional thickness along the bellows segment as compared to a nominal thickness of the side wall along at least a segment of the intermediate shell portion.

2. The nasal interface mask of claim 1 , wherein the bellows segment is further characterized by the side wall forming a first bend in longitudinal extension from the base.

3. The nasal interface mask of claim 2 , wherein the bellows segment includes the side wall defining a first section extending generally longitudinally from the base and a second section extending generally longitudinally from the first section toward the intermediate shell portion, and further wherein the first section forms the cavity to have a proximally decreasing transverse cross-sectional area to define the first bend relative to the base, and the second section forms the cavity to have a proximally increasing transverse cross-sectional area to define a second bend relative to the first section.

4. The nasal interface mask of claim 2 , wherein the side wall forms a second bend along the bellows segment in longitudinal extension from the base.

5. The nasal interface mask of claim 1 , wherein the leading portion includes a distal segment extending in a substantially longitudinal fashion from the intermediate shell portion, and a proximal segment extending in a substantially lateral fashion from the distal segment to the leading edge.

6. The nasal interface mask of claim 5 , wherein a wall thickness of the mask body along the proximal segment is less than a wall thickness of the mask body along the intermediate shell portion.

7. The nasal interface mask of claim 5 , wherein a transition from the distal segment to the proximal segment forms a curve in longitudinal cross-section.

8. The nasal interface mask of claim 1 , wherein the leading portion forms a patient contact face in a plane generally perpendicular to a longitudinal axis defined by the base, the patient contact face including a lip region configured for placement at a patient's upper lip, and first and second side regions extending from opposite ends of the lip region and connecting at a bridge region formed opposite the lip region to define a substantially triangular shape, and further wherein a perimeter of the first and second side regions forms an ocular relief.

9. The nasal interface mask of claim 8 , wherein the perimeter of the first and second side regions defines a first and a second concave curvatures in extension from the lip region to the bridge region relative to a frontal plane of the mask, the first and second concave curvatures comprising the ocular relief.

10. The nasal interface mask of claim 1 , wherein the leading portion forms a patient contact face in a plane generally perpendicular to a longitudinal axis defined by the base, the patient contact face including a lip region configured for placement a patient's upper lip, and first and second side regions extending from opposite ends of the lip region and connecting at a bridge region formed opposite the lip region to define a substantially triangular shape, and further wherein the lip region defines a septal relief feature.

11. The nasal interface mask of claim 10 , wherein the septal relief feature is characterized by the lip region forming a laterally outward, convex curvature.

12. The nasal interface mask of claim 1 , wherein a first zone of the mask body has an opacity less than an opacity of a second zone to define a viewing window.

13. The nasal interface mask of claim 12 , wherein the intermediate shell portion defines a bottom face and a top face, the nasal interface mask being configured to generate a desired orientation upon placement over a nose of a patient in which the bottom face is proximate an upper lip of the patient and the top face is adjacent a bridge of the patient's nose, and further wherein the first zone is defined in the bottom face to facilitate viewing a patient's septum and nares during use.

14. The nasal interface mask of claim 1 , wherein a nominal thickness of the side wall along the bellows segment is at least 50% less than a nominal thickness of the side wall along the intermediate shell portion.

15. The nasal interface mask of claim 1 , wherein a nominal thickness of the side wall along at least a segment of the leading portion is less than a nominal thickness of the side wall along at least a segment of the intermediate shell portion.

16. The nasal interface mask of claim 1 , wherein the leading portion forms a patient contact face in a plane generally perpendicular to a longitudinal axis defined by the base, the patient contact face including a lip region configured for placement at a patient's upper lip, and first and second side regions extending from opposite ends of the lip region and connecting at a bridge region formed opposite the lip region to define a substantially triangular shape, and further wherein relative to a side plane of the mask, each of the side first and second regions forms a convex curvature feature.

17. The nasal interface mask of claim 1 , wherein the base is configured to define, in transverse cross-section, opposed first and second side edges, and opposed first and second end edges, and further wherein a transition between the first end edge and the first side edge defines a radius of curvature greater than a radius of curvature defined at a transition between the first end edge and the second side edge.

18. The nasal interface mask of claim 1 , wherein the at least one passage includes a pair of passages extending through a thickness thereof, and a channel extending between, and fluidly connected to, the pair of passages.

19. The nasal interface mask of claim 1 , wherein apart from the opening in the rear face and a fluid connection to the cavity, the at least one passage is closed relative to an exterior of the base.

20. The nasal interface mask of claim 1 , wherein the bellows segment includes a plurality of ribs projecting outwardly to resist contraction of the bellows segment.

21. A nasal continuous positive airway pressure (nCPAP) device for use in an nCPAP system, the device comprising:

an nCPAP generator comprising:

first and second tubes fluidly connected to a fluid supply port, the nCPAP generator adapted to generate a continuous positive airway pressure within each of the first and second tubes; and

a nasal mask mounted to the first and second tubes, the mask comprising:

a mask body forming a cavity and defined by a leading portion, an intermediate shell portion, and a trailing portion, wherein:

the leading portion terminates in a leading edge forming an aperture open to the cavity and having a generally triangular shape for placement over a patient's nose,

the trailing portion includes a bellows segment characterized by an increased flexibility as compared to a flexibility of the intermediate shell portion, and

the bellows segment includes one or more ribs projecting laterally outwardly along a section of a side wall of the bellows segment in the mask body to resist contraction of the bellows segment and to apply a force to revert the bellows segment to an uncompressed state, and

a base extending from the trailing portion opposite the leading portion, the base forming a pair of passages extending in a longitudinal fashion through a thickness of the base and fluidly connected to the cavity, respective ones of the pair of passages being sized for assembly over a respective one of the first and second tubes,

wherein the nCPAP generator further comprises a housing laterally surrounding the first and second tubes, the housing sized to receive the base, and

wherein the base and the housing define corresponding, nonsymmetrical perimeter shapes.

22. The nCPAP device of claim 21 , wherein upon final assembly, the nCPAP device is configured such that the intermediate shell portion is laterally pivotably relative to the base and the first and second tubes in a multiplicity of directions.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Dec 13, 2024
From: VYAIRE MEDICAL, INC., ET AL.'S CREDITORS
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069635/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2024
From: VYAIRE MEDICAL CONSUMABLES LLC
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069455/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2024
From: ZOLLINGER, CHRIS; PIERRO, BRIAN
To: ALLEGIANCE CORPORATION
Reel/Frame 069425/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2024
From: ALLEGIANCE CORPORATION
To: CARDINAL HEALTH CMP 200, INC.
Reel/Frame 069425/0385 →
CHANGE OF NAME Recorded Nov 27, 2024
From: CARDINAL HEALTH CMP 200, INC.
To: CAREFUSION 2200, INC.
Reel/Frame 069462/0606 →
SECURITY INTEREST Recorded May 9, 2019
From: VYAIRE MEDICAL CONSUMABLES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049147/0928 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VYAIRE MEDICAL CONSUMABLES LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0940 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VYAIRE MEDICAL CONSUMABLES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045969/0830 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2018
From: CITIZENS BANK, N.A.
To: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; CAREFUSION 202, INC.; VITAL SIGNS, INC.
Reel/Frame 045779/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: CAREFUSION 2200, INC.
To: KINGSTON RESPIRATORY 102 LLC
Reel/Frame 040648/0009 →
CHANGE OF NAME Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY CONSUMABLES LLC
To: VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 040648/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY 102 LLC
To: KINGSTON RESPIRATORY CONSUMABLES LLC
Reel/Frame 040648/0047 →
SECURITY AGREEMENT Recorded Oct 14, 2016
From: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; VITAL SIGNS, INC.; CAREFUSION 202, INC.
To: CITIZENS BANK, N.A, AS COLLATERAL AGENT
Reel/Frame 040357/0952 →